PEN - Axsome Reports Positive Data And Other News: The Good Bad And Ugly Of Biopharma September, 21 2020 01:06 PM Penumbra Inc. Axsome reports positive data from Major Depressive Disorder study. Penumbra suffers setback as new catheter falters. Enanta begins NASH clinical study for EDP-297. For further details see: Axsome Reports Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma